In this article, we summarize what is and what is not known about managing type 2 diabetes during the Covid-19 pandemic, discuss recommendations made to date, review the implications of the latest real-world evidence, and make our own suggestions for patients who are returning to normal care after recovery from Covid-19
outlined several systemic advantages of GLP-1 RAs, including weight loss, glycemic control, cardiovascular protection (e.g., reduced incidence of myocardial infarction and stroke), and their role as a non-surgical alternative to bariatric procedures
Some never get adequate appetite suppression
Dose Adjustments: Renal Insufficiency: Patients with severe kidney disease require very close monitoring
The initial weeks of GLP-1 therapy represent an adjustment period as your body adapts to the medication